Sign up for free insights newsletter
GA

Galenica Sante AG

GALESIX Swiss Exchange

Need professional-grade analysis? Visit stockanalysis.com

CHF 89.75
-2.07%
End of day
Market Cap

$4.77B

P/E Ratio

26.15

Employees

4,727

Dividend Yield

2.65%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-2.64-2.83-1.660.891.030.76-0.04
Calmar-21.21-6.63-2.241.001.140.52-1.44
Sharpe-69.44-2.82-1.420.700.780.57-3.49
Omega0.000.300.721.151.161.120.94
Martin-32.61-10.47-5.633.103.901.30-1.60
Ulcer2.747.495.054.113.707.615.29

Galenica Sante AG (GALE) Price Performance

Galenica Sante AG (GALE) trades on SIX Swiss Exchange in CHF. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at CHF89.75, down 2.07% from the previous close.

Over the past year, GALE has traded between a low of CHF75.77 and a high of CHF102.80. The stock has gained 14.2% over this period. It is currently 12.7% below its 52-week high.

Galenica Sante AG has a market capitalization of $4.77B, with a price-to-earnings ratio of 26.15 and a dividend yield of 2.65%.

About Galenica Sante AG

Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates and manages pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients at home; laboratory medicine, pathology and specialized personalized diagnostic services; and develops, markets, and sells healthcare services and products through various distribution channels. The Logistics & IT segment provides various specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers master data systems for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as offers complete management solutions for pharmacies. In addition, it provides on-schedule delivery services to pharmacies, drugstores, doctors, hospitals, and care homes. The company was founded in 1927 and is headquartered in Bern, Switzerland.

Company Info

Exchange
SIX Swiss Exchange
Currency
CHF

Financial Metrics

Revenue (TTM)
$4.15B
EBITDA
$267.46M
Profit Margin
4.37%
EPS (TTM)
3.66
Book Value
29.74

Technical Indicators

52 Week High
CHF 103.00
52 Week Low
CHF 75.67
50 Day MA
CHF 97.74
200 Day MA
CHF 90.52
Beta
0.33

Valuation

Trailing P/E
26.15
Forward P/E
20.79
Price/Sales
1.15
Price/Book
3.22
Enterprise Value
$4.90B